Professor, The Institute of Medical Science, University of Tokyo
BIOGRAPHY
Speaker
Abstract
At the end of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), emerged in China. As of September 2022, SARS-CoV-2 is still ongoing pandemic: more than six hundred million cases of SARS-CoV-2 infection have been reported worldwide, with more than six million people dying of COVID-19. During the spreading worldwide, SARS-CoV-2 has been diversified, and these SARS-CoV-2 variants are considered to be the potential threats to the human society. In this talk, I will introduce our recent findings on a series of SARS-CoV-2 variants.
Learning Objectives:
1. Discuss the current and future situation of COVID-19 pandemic.
2. Explain the impact of novel SARS-CoV-2 variants.
3. Evaluate what we should do to continue to control this pandemic.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...